We know how to reach it, and we've been doing so since 2016. We've run forums for regulatory affairs professionals, marketed enterprise software into pharma, and built demand among audiences that ignore conventional marketing. What we don't do is pretend to be a subject matter expert in your product. That's what your people are for, and the work is better when we use them properly.

Retainers start at £5,000 a month plus VAT. Project work, brand and website builds among them, is quoted separately.

Not cold outreach on its own, no. What works is giving them a reason to know who you are before you ask for anything: a forum worth attending, research they can't get elsewhere, a peer they'd trust telling them you're worth a conversation. Outreach then does a different job, and gets a different response rate.

Not wrong, usually under-used. Most firms spend heavily on the stand and almost nothing on the six weeks either side. The meetings that matter are booked before the doors open, and the pipeline is built afterwards. We work the whole cycle rather than the three days in the middle. We’ve supported clients at pharma industry events such as L-Ten and Momentum.

By measuring the things that come before revenue. Which named accounts are engaging, how many people inside them, whether the right job titles are showing up, whether conversations are starting. If four people from one company attend your forum, that tells you something a lead count won't. We agree on those measures before we start.

Yes, and we plan for it rather than discovering it late. Claims are evidenced, drafts are built to clear review rather than be corrected after it, and we work to the approval timelines that exist. We're not your regulatory function and we don't sign anything off.

That’s not a problem, many of our tech clients do. The key is understanding the nuances between sectors and that a one size fits all approach won’t work. Part of the strategic analysis is working out what genuinely transfers and what needs building separately, rather than paying twice for the same thing or once for something that only lands in one place.